Filing Details
- Accession Number:
- 0000950170-24-097309
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-14 19:01:29
- Reporting Period:
- 2024-08-05
- Accepted Time:
- 2024-08-14 19:01:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1697532 | Applied Therapeutics Inc. | APLT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1775490 | Shoshana Shendelman | C/O Applied Therapeutics, Inc. 545 Fifth Avenue, Suite 1400 New York NY 10017 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-05 | 747,886 | $0.00 | 0 | No | 4 | G | Indirect | See footnote |
| Common Stock | Acquisiton | 2024-08-05 | 747,886 | $0.00 | 747,886 | No | 5 | G | Indirect | See footnote |
| Common Stock | Disposition | 2024-08-12 | 300,000 | $5.98 | 5,167,853 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-08-13 | 357,423 | $6.18 | 4,810,430 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-08-14 | 119,591 | $5.93 | 4,690,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Indirect | See footnote |
| No | 5 | G | Indirect | See footnote |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,492,094 | Indirect | See footnote |
| Common Stock | 290,280 | Indirect | See footnote |
| Common Stock | 88,397 | Indirect | See footnote |
Footnotes
- Through a grantor retained annuity trust. Upon termination of the trust, 747,886 shares of the issuer's common stock were distributed to a family trust controlled by the reporting person. The remaining shares were distributed to the reporting person and continue to be reported in this Form 4 as directly owned.
- Through a family trust controlled by the reporting person.
- Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.57 to $6.205, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.82 to $6.39, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.825 to $6.265, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Through a family trust controlled by the reporting person.
- Through a family trust controlled by the reporting person.
- Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
Billionaire Hedge Funds
